InvestorQ : What is the latest deal between Novavax and Serum and how it impacts the COVID race?
Dia Deshpande made post

What is the latest deal between Novavax and Serum and how it impacts the COVID race?

Answer
user profile image
swati Bakhda answered.
2 weeks ago


It is not a new deal but an extension of the existing deal between Novavax of the US and Pune based Serum Institute; part of the Cyrus Poonawala group. Serum and Novavax already have an agreement to produce 2 billion doses of Covid-19 vaccines for low and middle income countries.

Now, under the extended agreement, Serum Institute will additionally manufacture the antigen component of NVX‑CoV2373, the COVID vaccine candidate of Novavax. Novavax, like other American companies, is keen to de-risk its supply chain from excessive China dependence.

Novavax vaccine candidate is in mid-stage trials after the early-stage trial results showed high levels of antibodies generated by the vaccine against Coronavirus. The next stage of the trial will happen in late Oct-20 after said vaccines are manufactured by Serum of Pune.

In more updates on the vaccine front; Bharat Biotech and Cadila Healthcare completed Phase-1 trials of their respective vaccines while Serum has completed II-B3 trials with 1500 patients. Pfizer and Moderna have also begun late stage trials even as Astra Zeneca is also consolidating Phase 3.